Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotherapeutic
|
| gptkbp:basedOn |
engineered probiotic bacteria
|
| gptkbp:developedBy |
gptkb:Synlogic
|
| gptkbp:example |
gptkb:SYNB1618
gptkb:SYNB1934 |
| https://www.w3.org/2000/01/rdf-schema#label |
Synthetic Biotic medicines
|
| gptkbp:mechanismOfAction |
modification of gut microbiome
|
| gptkbp:regulates |
investigational
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
in clinical trials
|
| gptkbp:target |
gptkb:phenylketonuria
|
| gptkbp:usedFor |
treatment of metabolic diseases
treatment of rare genetic diseases |
| gptkbp:bfsParent |
gptkb:Synlogic
|
| gptkbp:bfsLayer |
6
|